Win Medica Pharmaceutical S.A.

Win Medica Pharmaceutical S.A. supports clinical research in atrial fibrillation, with a particular focus on restoring sinus rhythm in patients presenting with recent-onset or paroxysmal atrial fibrillation. The sponsored studies examine treatment options used in the Emergency Department and in patients with coronary artery disease and preserved left ventricular function.

• Cardioversion of paroxysmal atrial fibrillation
• Restoration of sinus rhythm
• Emergency Department arrhythmia management

The research activity in this area centers on antiarrhythmic treatment strategies relevant to acute rhythm control and clinical decision-making in patients with symptomatic atrial arrhythmias.